![]() |
Volumn 152, Issue 2-3, 2005, Pages 165-168
|
Letter to the Editor (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBAMAZEPINE;
HALOTHANE;
ISONIAZID;
LIPOPOLYSACCHARIDE;
MINOCYCLINE;
PROCAINAMIDE;
PYRAZINAMIDE;
RANITIDINE;
TIENILIC ACID;
TROGLITAZONE;
DRUG;
ANAPHYLAXIS;
APLASTIC ANEMIA;
AUTOIMMUNITY;
BONE MARROW TOXICITY;
CORRELATION ANALYSIS;
DRUG HYPERSENSITIVITY;
DRUG RESPONSE;
DRUG SENSITIZATION;
DRUG TARGETING;
HUMAN;
IMMUNE SYSTEM;
IMMUNITY;
IMMUNOLOGICAL TOLERANCE;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
LIVER INJURY;
LIVER NECROSIS;
LIVER TOXICITY;
NONHUMAN;
PREDICTION;
RASH;
SINGLE NUCLEOTIDE POLYMORPHISM;
SYSTEMIC LUPUS ERYTHEMATOSUS;
ANIMAL;
ANIMAL MODEL;
AUTOIMMUNE DISEASE;
CHEMICALLY INDUCED DISORDER;
DRUG SURVEILLANCE PROGRAM;
IMMUNOLOGY;
LIVER DISEASE;
NOTE;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
ANIMALS;
AUTOIMMUNE DISEASES;
HUMANS;
LIVER DISEASES;
MODELS, ANIMAL;
PHARMACEUTICAL PREPARATIONS;
|
EID: 17144389849
PISSN: 00092797
EISSN: None
Source Type: Journal
DOI: 10.1016/j.cbi.2005.02.001 Document Type: Letter |
Times cited : (3)
|
References (0)
|